Monitoring of circulating tumor plasma cells in patients with precursor conditions of multiple myeloma: Data from the Prospective Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Sigurbergsdóttir, A. Ý., Rögnvaldsson, S., Thorsteinsdottir, S., Sverrisdottir, I. S., Sigurdardottir, G. A., Vidarsson, B., Onundarson, P. T., Agnarsson, B. A., Sigurdardottir, M., Thorsteinsdottir, I., Olafsson, I., Thordardottir, A. R., Gislason, G. K., Olafsson, A., Kampanis, P., Hultcrantz, M., Durie, B. G. M., Harding, S., Landgren, O., Love, T. J. & Kristinsson, S. Y.

Journal title: Blood

Journal number: 138 (Supplement 1)

Journal publisher: ASH Publications

Published year: 2021

Published pages: 2645

DOI identifier: 10.1182/blood-2021-146363

ISSN: 0006-4971